Current status of the Strecker stent

Area of Science:

• Vascular surgery
• Biomaterials science
• Interventional cardiology

Background:

• Knitted flexible tantalum stents are effective adjuncts to percutaneous transluminal angioplasty (PTA) for insufficient PTA results.
• Stent use is established in major arteries (aorta, iliac, femoro-popliteal, renal, coronary) and extended to new indications like long arterial occlusions and smaller vessels (subclavian, carotid, splanchnic).

Purpose of the Study:

• To evaluate the established and extended indications for knitted flexible tantalum stents.
• To highlight the importance of patient selection for stenting in small diameter arteries.
• To introduce the potential of drug-releasing stents in mitigating late restenosis.

Main Methods:

• Review of clinical applications of knitted flexible tantalum stents.
• Analysis of indications for primary stenting in long arterial occlusions.
• Discussion of complications associated with stenting in small diameter arteries.
• Reference to animal experiments with drug-releasing stents.

Main Results:

• Tantalum stents have proven valuable in treating insufficient PTA results across multiple arterial locations.
• Stent indications have expanded to include long occlusions and previously untreated arterial segments.
• Higher complication rates necessitate careful patient selection for stenting in small arteries.
• Drug-eluting stents show promise in reducing intimal hyperplasia and improving long-term patency.

Conclusions:

• Knitted flexible tantalum stents are a valuable tool in vascular interventions.
• Careful patient selection is paramount, especially for stenting in small diameter arteries.
• Drug-eluting stents represent a promising advancement for improving long-term outcomes by reducing restenosis.